Study of MLN8237 in Participants With Advanced Hematological Malignancies

NCT00697346 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Follicular Lymphoma
B-cell Marginal Zone Lymphoma
Diffuse Large B-cell Lymphoma
B-cell Mantle Cell Lymphoma
B-cell Small Lymphocytic Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Multiple Myeloma
Waldenstrom's Macroglobulinemia
Noncutaneous Peripheral T-cell Lymphoma Not Otherwise Specified
Angioimmunoblastic T-cell Lymphoma
Anaplastic Large Cell Lymphoma
Enteropathy Associated T-cell Lymphoma
NK Lymphoma

Interventions

DRUG: Alisertib

Sponsor

Millennium Pharmaceuticals, Inc.